Company Number: 14154382

Analysis Date: 2025-07-29 15:41 UTC

1. Credit Opinion: CONDITIONAL APPROVAL
   Tutela Vitae Group Limited is a micro private limited company operating in private security activities. The company is very young (incorporated in 2022) and has demonstrated small but positive net asset growth and maintained positive working capital. However, the scale of operations is minimal with only one employee and limited fixed and current assets. The company’s ability to service debt is currently adequate but constrained by its small size and modest equity base. Credit approval is recommended subject to ongoing monitoring and possibly limiting exposure given the company's early stage and small financial footprint.

2. Financial Strength:
   The balance sheet shows modest net assets of £2,248 as of June 2024, up from £1,505 in June 2023, indicating slight growth in equity. Fixed assets have slightly decreased from £4,052 to £3,445, while current assets have declined more significantly from £15,905 to £11,518. Current liabilities have decreased from £10,952 to £6,215, improving net current assets to £5,303 from £4,953. Long-term liabilities have also reduced from £7,500 to £6,500. Overall, the company retains a positive net asset position but remains thinly capitalized with limited asset backing.

3. Cash Flow Assessment:
   Current assets exceed current liabilities by £5,303, reflecting a comfortable working capital position for day-to-day operations. However, the reduction in current assets and liabilities year over year suggests careful cash flow management is necessary. The company’s micro size and single employee status imply low overheads, but cash flow might be vulnerable to fluctuations in business activity. There is no indication of significant cash reserves or financial flexibility.

4. Monitoring Points:

• Track growth in turnover and profitability to ensure scaling beyond micro-entity status.
• Monitor working capital trends closely to avoid liquidity strain.
• Watch for increases in liabilities that could erode the small equity base.
• Review director and shareholder actions for evidence of sound financial management and potential infusion of capital if needed.
• Assess impact of any industry or regulatory changes in private security that might affect revenue or cost structure.